Capsules vs Gummies vs Liquids: Manufacturing Economics by Format

Why do gummies cost more to manufacture than capsules?

Gummies cost more because the process is slower and the inputs are pricier — cooking sugar syrup, molding, cooling and dusting each piece adds labor and equipment time that a capsule fill-and-cap line skips entirely. At roughly 5,000-unit runs, a published per-format cost table puts capsules at $2.50 to $5.00 per 60-count bottle against $4.00 to $8.00 or more for gummies, with liquids running even higher at $5.00 to $10.00 — a spread the Inventory Ready cost breakdown ties to more processing steps and pricier raw inputs.

Scale narrows the gap but never closes it. Capsule pricing on a standard 60-count SKU with common ingredients drops from roughly $3.50 to $4.50 per bottle at a 1,500-unit first run down to $1.50 to $2.50 at 25,000 units — the per-unit cost nearly halves — while gummy production carries a heavier fixed-cost floor from cooking equipment and molds that doesn't compress the same way. Anyone pricing a launch should read the line-item breakdown in what a supplement bottle actually costs from the manufacturer before quoting a number to a media buyer.

SMP Nutra's published FAQ frames the same gap at the vendor level: stock private-label runs $4 to $20 per unit and custom formulations $5 to $30, at a standard MOQ of 2,500 to 5,000 bottles per SKU, inclusive of bottling, testing, seals and labels but excluding freight. Gummies sit at the top of that range far more often than capsules do, because sugar, gelling agent, flavor and coating account for a larger share of the bill of materials than an empty shell and a powder fill.

How do MOQs differ across capsules, gummies, softgels, and liquids?

MOQs span three orders of magnitude, and the number that matters depends on whether you're buying stock or custom. Supliful advertises a zero-unit minimum on white-label dropship, filling "1 unit or 1,000" at the same price tier; Makers Nutrition lists private-label stock formulas from 500 units; SMP Nutra sets a hard floor of 1,000 bottles per SKU that its equipment cannot split across products.

Custom formulation resets all of those numbers upward, and gummies move the most. Going from a stock gummy formula — SMP Nutra lists runs starting as low as 1,000 bottles — to a custom gummy formula multiplies the minimum roughly tenfold.

The MOQ on a quote sheet isn't the only exposure — who owns the formula decides whether you can walk away from a bad one. Under true contract manufacturing the brand owns the formula only if the development agreement says so explicitly; under private label the manufacturer owns it and you cannot move it to another factory; under co-packing you keep the IP, per the breakdown from Atrium Sci. A 600,000-piece gummy MOQ locked into a manufacturer-owned formula is a very different risk than the same volume under a contract you control.

• Capsules/tablets (custom): 150,000–300,000 pieces, or 2,500–5,000 bottles
• Softgels (custom): 300,000 pieces, or 5,000 bottles
• Liquids (custom): 2,500–5,000 bottles
• Powders (custom): 2,500 bottles per flavor, or 500 kg
• Gummies (custom): 600,000–1,000,000 pieces, or 10,000–16,000 bottles at 60-count
• Gummies (stock formula): as low as 1,000 bottles

Which format has the fastest production lead times?

Capsules and tablets move fastest, with published lead times of 4 to 8 weeks from PO to finished goods; gummies run 8 to 12 weeks, and stick packs run 8 to 14. Layered on top of format, the manufacturing model itself adds or removes weeks: stock formulas ship in 2 to 4 weeks, private label in 4 to 8, and full custom formulation in 8 to 16, per Inventory Ready's lead-time data.

Individual vendors publish tighter windows than the industry range, and it's worth asking which one you're being quoted against. SMP Nutra states 8 to 10 weeks for new customers measured from label reception and 6 to 8 weeks on reorders with labels already on file, while Superior Supplement Manufacturing claims a private-label order can be produced, packaged and delivered in 3 to 4 weeks — a figure well below the general range and worth confirming against your own SKU before you build a launch calendar on it.

Two things blow up any quoted timeline. Sourcing a specialty or imported ingredient can add 4 to 6 weeks versus using something already in stock, and 21 CFR 111.75 requires identity testing on every unique incoming lot, adding a minimum of 5 to 10 days that most launch calendars don't budget for. Both compound during Q3 and Q4, when manufacturer capacity tightens across the board — the worst quarters to assume a vendor's best-case number holds.

How do shelf life and stability differ by format?

Capsules hold up longest and are the format manufacturers reach for when shelf life matters; gummies are rated for about a year and up to two years only in optimal storage, and they physically fuse into a single mass above 90°F. Ambient-stability programs for most formats are built around 12 to 24 month windows, tested quarterly in year one and semi-annually in year two, per Vitaquest's stability-testing guidance — but a gummy SKU sitting in a non-climate-controlled warehouse in July can fail well before its printed date says it should.

Probiotics complicate the picture further and often ride inside a gummy matrix. They need real-time CFU viability validation across roughly 6 to 24 months, and formulators build in nutrient overages of 3 to 25% (higher for probiotics specifically) so the product still meets label claim at expiration — a cost that scales with however long a shelf life you commit to, not a fixed per-unit fee.

FDA does not require an expiration date on a supplement label at all; its own labeling guidance says a firm may include one only if it is supported by valid data. Once you print a date, though, 21 CFR 111.605(a) binds you to keep cGMP batch records for a full year past it — so a shorter-lived gummy SKU carries a shorter, cheaper recordkeeping tail than a two-year capsule run, one of the only places gummy economics work in the format's favor.

Do gummies actually convert better on cold traffic?

No verified split-test data ties gummy format to a specific conversion lift on cold traffic, and any percentage you've seen quoted in a swipe file needs checking before you build a media plan on it. What's demonstrable is the input side of the trade: a gummy SKU costs $4.00 to $8.00-plus per bottle against $2.50 to $5.00 for capsules at the same run size, its custom MOQ runs 600,000 to 1,000,000 pieces against 150,000 to 300,000, and it carries a shelf-life clock roughly half as long.

Even granting the common claim that a gummy's taste and format novelty lift landing-page conversion, the math has to clear a higher bar before it pays back — the format needs a lift large enough, sustained long enough, to offset a MOQ that's four to six times larger and a per-unit cost that's roughly double. Most operators never run that comparison; they copy a competitor's format because a VSL claims their gummy "converts better," without checking whether the cost structure supports the volume that claim assumes.

Treat "gummies convert better" as a hypothesis to test at small volume, not received wisdom to build a launch around. A capsule offer that converts adequately and reorders cleanly at 2,500 bottles beats a gummy bet that converts better on paper but leaves you holding 10,000 bottles of a product with a 12-month clock.

Which active ingredients can't go into a gummy?

Nothing is banned outright, but four categories consistently get excluded or reformulated before a gummy matrix can carry them. High-dose minerals such as calcium and magnesium take up too much volume and taste chalky or metallic at label-friendly doses, so brands split the dose across multiple gummies or drop the format. Exact per-gummy ceilings vary by manufacturer and formula, so treat any specific milligram number you're quoted as needing confirmation from the factory, not a fixed industry rule.

Heat- and moisture-sensitive actives are the second problem, and probiotics sit at the center of it — the same real-time CFU viability testing that ambient-stability programs require for probiotics over roughly 6 to 24 months gets harder to pass once a strain has been through a hot-pour gummy cook and then stored above 90°F, the temperature at which gummies are documented to fuse. Enzymes and some botanicals with volatile actives face a version of the same problem.

Fat-soluble vitamins (D, E, K) need emulsification before a gummy matrix holds them evenly, an extra formulation step capsules and softgels skip. And anything with a narrow, precise dosing requirement is a harder sell in a gummy, where piece-to-piece weight variance runs higher than a machine-filled capsule. None of this rules gummies out — it just means the ingredient list should be the first thing you check before committing to the format, not the last.

Which format should a first offer launch with?

For a first offer with unproven demand, capsules are the lower-risk starting format on every axis that matters before you know if the offer sells: MOQ as low as 500 to 1,000 units from private-label vendors like Makers Nutrition or SMP Nutra, lead times of 4 to 8 weeks, and a shelf life long enough that you aren't racing a clock while you test creative. The downside is real too — capsules are a commodity format, and a VSL claiming a gummy "tastes better" or "is easier to take" is claiming something about the product experience, not something the format guarantees on its own.

Liquids and gummies earn their place once an offer has proven demand and you have sales velocity data to size the commitment against. A 5,000 to 16,000-bottle gummy MOQ is a reasonable bet against a SKU already converting; it's a bad bet against a hypothesis. The same logic applies to setup costs — formulation development, stability testing, molds and COA testing together add 20 to 40% on top of quoted per-unit prices, per Inventory Ready, and that premium is easier to absorb once revenue is already covering it.

Whichever format you choose, price the refund exposure into the launch, not after it. A gummy SKU that arrives melted, or a capsule batch a customer decides didn't work, generates a return or a chargeback either way, and the economics of a refund-before-dispute policy change depending on how much margin the format left you to work with in the first place.

Quick decision checklist

Use this page as a decision aid, not a generic blog post. The practical question is whether the reader needs faster evidence about what is already working in VSL-driven direct response, especially across nutra, supplements, GLP-1, weight loss, blood sugar, and adjacent high-intent health markets.

Daily Intel Service is most relevant when the next decision depends on active market examples: which hook to test, which claim style is risky, which funnel structure is common, which language market is moving, and whether a competitor's creative is likely early, scaling, or already saturated.

• Start with the TL;DR if you need the direct answer.
• Use the table to compare trade-offs quickly.
• Use the FAQ for answer-engine-ready summaries.
• Use the CTA when the decision requires live VSL and ad examples instead of theory.

Daily Intel's coverage advantage

Daily Intel Service is positioned around category-leading variety and actionability: one of the broadest direct-response catalogs of VSLs and ad creatives across blackhat, greyhat, and whitehat advertising patterns, with enough context to understand what the advertiser is doing beyond the visible creative. The practical difference is that members are not just seeing a screenshot; they are seeing the VSL, the ad, the funnel path, the transcript, the UTM context, and the research notes that turn the asset into a decision.

This matters because direct-response affiliates do not operate in one clean category. A weight-loss campaign may use a whitehat compliance ad, a greyhat pre-lander, a more aggressive VSL, and a checkout path designed around upsells and recovery. A useful intelligence platform needs to capture that spectrum instead of pretending every winning campaign looks like a public brand ad.

Blackhat, whitehat, and multilingual signal coverage

Daily Intel tracks patterns across both blackhat-style and whitehat-style campaigns so operators can understand the market without blindly copying risk. Whitehat examples help with durability and compliance review; blackhat and greyhat examples reveal pressure points, hooks, mechanisms, and funnel structures that may be driving spend but require careful adaptation before use.

The catalog is also built for global operators, with VSL and ad references spanning 14+ languages and different local idioms. That is a key advantage for Brazilian, LATAM, European, MENA, Indian, and non-native English affiliates who need to see how the same market desire is translated across cultures instead of only studying US English ads.

How to use the intelligence responsibly

The goal is modeling, not copying. Use Daily Intel to understand structure: hook, mechanism, proof, claim intensity, funnel depth, offer economics, and saturation stage. Then build original creative, review claims, and adapt the angle to the traffic source, country, language, and compliance requirements of the campaign.

A strong workflow compares multiple examples before acting. If the same mechanism appears across several languages, several advertisers, and several funnel variants, it may be a durable market signal. If the example appears only once or depends on an aggressive claim, treat it as a research clue rather than a campaign template.

• Model structure, not protected creative assets.
• Separate whitehat durability from blackhat persuasion pressure.
• Compare US English examples against LATAM, European, and other language variants.
• Use transcripts and funnel notes to build original briefs.
• Keep compliance review separate from market research.

Methodology and source context

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

For educational pages, the supporting references should help readers verify search, crawlability, and public ad research context, especially Google helpful content guidance, Google SEO link best practices, and Meta Ad Library. Daily Intel then adds the direct-response interpretation layer so the page explains what the signal means for actual affiliate research decisions.

For deeper evaluation, continue through Daily Intel research methodology, How to Turn One Winning Angle Into 20 Hook Variants, Tipos de Hook Para Criativos: 12 Padrões Que Escalam, Creative Testing Win Rate: What Percent of Ads Win?, How Many Ads Your Competitor Runs: Reading the Count, and What is a VSL?. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.